Cystic Fibrosis Clinical Trials

Birmingham : UAB/CHS Cystic Fibrosis Center

I Change Adherence & Raise Expectations

Birmingham : Site Reference ID/Investigator# 78920

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Birmingham : University of Alabama at Birmingham Updated

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Birmingham :

Rollover Study of Ivacaftor in Subjects With Cystic Fibrosis and a Non G551D CFTR Mutation

Birmingham : University of Alabama

Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation

View More »

Birmingham : The University of Alabama at Birmingham

Safety and Tolerability Trial of Inhaled Alpha1-Proteinase Inhibitor (Human), Hydrophobic Chromatography Process (Alpha-1 HC) in Subjects With Cystic Fibrosis

Birmingham :

Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CTFR Gating Mutation

Birmingham :

Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation

Birmingham : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Mobile :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Anchorage : Site Reference ID/Investigator# 79256

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Phoenix : Phoenix Children's Hospital

I Change Adherence & Raise Expectations

Phoenix : Phoenix Children's Hospital Updated

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Phoenix :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Tucson : University of Arizona Medical Center Updated

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Tucson :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Little Rock :

A Study of the Comparable Efficacy and Safety of Pulmozyme (Dornase Alfa) Delivered by the eFlow Rapid Nebulizer System in Patients With Cystic Fibrosis

Little Rock : Site Reference ID/Investigator# 79265

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Little Rock :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

La Jolla : University of California - San Diego Updated

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Long Beach :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Los Angeles : University of Southern California

Prospective Observational Study to Evaluate Biomarkers of Aminoglycoside Nephrotoxicity in Patients With Cystic Fibrosis

Oakland : Kaiser Permanente Medical Care Program

I Change Adherence & Raise Expectations

Oakland : Site Reference ID/Investigator# 79295

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

View More »

Oakland : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Oakland :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Orange :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Palo Alto :

Rollover Study of Ivacaftor in Subjects With Cystic Fibrosis and a Non G551D CFTR Mutation

Palo Alto :

Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation

Stanford :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Aurora : Site Reference ID/Investigator# 79277

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Aurora : Children's Hospital Colorado

Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation

Aurora :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Denver : Site Reference ID/Investigator# 76784

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Denver : National Jewish Health Updated

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

View More »

Denver :

Pilot Study Testing the Effect of Ivacaftor on Lung Function in Subjects With Cystic Fibrosis and Residual CFTR Function

Denver : National Jewish Health

Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation

Denver : National Jewish Hospital

Safety and Tolerability Trial of Inhaled Alpha1-Proteinase Inhibitor (Human), Hydrophobic Chromatography Process (Alpha-1 HC) in Subjects With Cystic Fibrosis

Hartford : Connecticut Children's Medical Center

I Change Adherence & Raise Expectations

Hartford :

Rollover Study of Ivacaftor in Subjects With Cystic Fibrosis and a Non G551D CFTR Mutation

Hartford :

Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation

New Haven : Site Reference ID/Investigator# 78940

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Wilmington : Site Reference ID/Investigator# 78945

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Wilmington : Alfred I. duPont Hospital for Children Updated

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Washington : Site Reference ID/Investigator# 79373

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Washington : Children's National Medical Center Updated

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Altamonte Springs :

A Study of Lumacaftor in Combination With Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older Who Are Homozygous for the F508del-CFTR Mutation (TRAFFIC)

Altamonte Springs : Site Reference ID/Investigator# 76776

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Altamonte Springs : Central Florida Pulmonary Group Updated

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Gainesville : Site Reference ID/Investigator# 78928

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Gainesville : Site Reference ID/Investigator# 76790

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

View More »

Gainesville : University of Florida Updated

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Gainesville :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Hollywood : South Broward Hospital dba Memorial Healthcare System Updated

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Jacksonville : Site Reference ID/Investigator# 78898

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Miami : University of Miami - Miller School of Medicine Updated

Efficacy Study of AeroVanc for the Treatment of Persistent MRSA Lung Infection in Cystic Fibrosis Patients

Miami : University of Miami Updated

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Miami :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Orlando : Nemours Children's Clinic and Hospital Updated

Efficacy Study of AeroVanc for the Treatment of Persistent MRSA Lung Infection in Cystic Fibrosis Patients

Orlando : Site Reference ID/Investigator# 78917

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Orlando : Site Reference ID/Investigator# 96075

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Orlando : Nemours Children's Clinic - Orlando Updated

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

St. Petersburg : Site Reference ID/Investigator# 79264

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Tampa : New Lung Associates, PA; Lung Transplant, Adult Cystic Fibrosis, and the Center for Advanced Lung Diseases, Tampa General Hospital Updated

Efficacy Study of AeroVanc for the Treatment of Persistent MRSA Lung Infection in Cystic Fibrosis Patients

Tampa : Site Reference ID/Investigator# 76783

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Tampa : Tampa General Hospital Updated

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Tampa :

Rollover Study of Ivacaftor in Subjects With Cystic Fibrosis and a Non G551D CFTR Mutation

Tampa :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Atlanta : Site Reference ID/Investigator# 79394

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Atlanta :

Rollover Study of Ivacaftor in Subjects With Cystic Fibrosis and a Non G551D CFTR Mutation

Atlanta :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Augusta : Site Reference ID/Investigator# 79395

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Augusta : Georgia Health Updated

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Boise : St. Lukes Medical Center Updated

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Boise : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Chicago : Children's Memorial Hospital

I Change Adherence & Raise Expectations

Chicago : Site Reference ID/Investigator# 79296

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Chicago : University of Chicago Updated

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Chicago :

Rollover Study of Ivacaftor in Subjects With Cystic Fibrosis and a Non G551D CFTR Mutation

Chicago :

Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation

View More »

Chicago : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Glenview : The Cystic Fibrosis Center of Chicago Updated

Efficacy Study of AeroVanc for the Treatment of Persistent MRSA Lung Infection in Cystic Fibrosis Patients

Indianapolis : Riley Hospital for Children

I Change Adherence & Raise Expectations

Indianapolis : Site Reference ID/Investigator# 78903

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Indianapolis : Riley Hospital for Children Updated

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Indianapolis :

Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CTFR Gating Mutation

Indianapolis :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Iowa City :

Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation

Iowa City :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Wichita : Via Christi Research Updated

BurliLipase in Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis

View More »

Kansas City : University of Kansas Medical Center Updated

Efficacy Study of AeroVanc for the Treatment of Persistent MRSA Lung Infection in Cystic Fibrosis Patients

Kansas City : University of Kansas Medical Center Updated

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Lexington : University of Kentucky Cystic Fibrosis Clinic Updated

Efficacy Study of AeroVanc for the Treatment of Persistent MRSA Lung Infection in Cystic Fibrosis Patients

Lexington :

Rollover Study of Ivacaftor in Subjects With Cystic Fibrosis and a Non G551D CFTR Mutation

Lexington :

Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation

Lexington :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Louisville :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

New Orleans : Site Reference ID/Investigator# 78916

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Portland : Maine Medical Center

I Change Adherence & Raise Expectations

Portland : Site Reference ID/Investigator# 78894

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Portland : Maine Medical Center Updated

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Portland :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Baltimore : Johns Hopkins University

Durability of Hypertonic Saline for Enhancing Mucociliary Clearance in Cystic Fibrosis

Baltimore : Site Reference ID/Investigator# 78893

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Baltimore :

Rollover Study of Ivacaftor in Subjects With Cystic Fibrosis and a Non G551D CFTR Mutation

Baltimore : Johns Hopkins Hospital

Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation

Baltimore :

Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation

Boston : Massachusetts General Hospital Pediatric Cystic Fibrosis Center Updated

Efficacy Study of AeroVanc for the Treatment of Persistent MRSA Lung Infection in Cystic Fibrosis Patients

Boston : Children's Hospital Boston

I Change Adherence & Raise Expectations

Boston : Site Reference ID/Investigator# 79254

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Boston : Site Reference ID/Investigator# 79276

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Boston : Site Reference ID/Investigator# 78895

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

View More »

Boston : Boston Children's Hospital Updated

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Boston :

Rollover Study of Ivacaftor in Subjects With Cystic Fibrosis and a Non G551D CFTR Mutation

Boston : Boston Children's Hospital

Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation

Boston : Children's Hospital Boston

Safety and Tolerability Trial of Inhaled Alpha1-Proteinase Inhibitor (Human), Hydrophobic Chromatography Process (Alpha-1 HC) in Subjects With Cystic Fibrosis

Boston : Children's Hosptital, Boston

Structure and Function of Salivary Proteins

Boston :

Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CTFR Gating Mutation

Boston :

Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation

Boston : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Boston :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Worcester : Site Reference ID/Investigator# 78954

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Worcester : UMass Memorial Medical Center Updated

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Worcester :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Ann Arbor : University of Michigan Health System

I Change Adherence & Raise Expectations

Ann Arbor : University of Michigan Updated

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Ann Arbor :

Rollover Study of Ivacaftor in Subjects With Cystic Fibrosis and a Non G551D CFTR Mutation

Detroit : Harper University Hospital Updated

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Detroit :

Rollover Study of Ivacaftor in Subjects With Cystic Fibrosis and a Non G551D CFTR Mutation

View More »

Detroit :

Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation

Detroit :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

East Lansing : Site Reference ID/Investigator# 78950

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Farmington Hills : Site Reference ID/Investigator# 79278

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Grand Rapids : Site Reference ID/Investigator# 79397

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Grand Rapids :

Rollover Study of Ivacaftor in Subjects With Cystic Fibrosis and a Non G551D CFTR Mutation

Grand Rapids :

Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CTFR Gating Mutation

Grand Rapids :

Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation

Grand Rapids : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Grand Rapids :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Minneapolis : Updated

A Study of Lumacaftor in Combination With Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older Who Are Homozygous for the F508del-CFTR Mutation (TRANSPORT)

Minneapolis : University of Minnesota

A Study of Sweat Testing Using a Quantitative Patch

Minneapolis : Site Reference ID/Investigator# 79253

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Minneapolis : Site Reference ID/Investigator# 76791

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Minneapolis : University of Minnesota - Cystic Fibrosis Center

Prospective Observational Study to Evaluate Biomarkers of Aminoglycoside Nephrotoxicity in Patients With Cystic Fibrosis

View More »

Minneapolis :

Rollover Study of Ivacaftor in Subjects With Cystic Fibrosis and a Non G551D CFTR Mutation

Minneapolis : University of Minnesota

Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation

Minneapolis :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Jackson : University of Mississippi Medical Center Updated

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Kansas City : Site Reference ID/Investigator# 78948

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Kansas City :

Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CTFR Gating Mutation

Kansas City : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Kansas City :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

St. Louis : Washington University School of Medicine Updated

Efficacy Study of AeroVanc for the Treatment of Persistent MRSA Lung Infection in Cystic Fibrosis Patients

View More »

St. Louis : Site Reference ID/Investigator# 79275

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

St. Louis :

Rollover Study of Ivacaftor in Subjects With Cystic Fibrosis and a Non G551D CFTR Mutation

St. Louis : Washington University

Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation

St. Louis :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Omaha : University of Nebraska Medical Center Updated

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Omaha :

Rollover Study of Ivacaftor in Subjects With Cystic Fibrosis and a Non G551D CFTR Mutation

Omaha :

Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation

Las Vegas : Children's Lung Specialists Updated

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Bedford : Dartmouth Hitchcock Specialty Care Clinic Updated

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Lebanon : Dartmouth Hitchcock Medical Center Updated

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Manchester : Site Reference ID/Investigator# 78957

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Long Branch : Site Reference ID/Investigator# 78901

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Long Branch : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Morristown : Site Reference ID/Investigator# 76782

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Morristown : Morristown Medical Center Updated

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Albuquerque : UNM Clinical and Translational Center Updated

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

New Hyde Park : Biomedical Research Alliance of New York

Cystic Fibrosis

View More »

Albany : Updated

A Study of Lumacaftor in Combination With Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older Who Are Homozygous for the F508del-CFTR Mutation (TRANSPORT)

Albany : Albany Medical College Updated

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Albany :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Buffalo : Women and Children's Hospital of Buffalo

I Change Adherence & Raise Expectations

Buffalo : Site Reference ID/Investigator# 78941

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Hawthorne :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

New Hyde Park : Long Island Jewish Medical Center - Adult CF & Bronchiectasis Center Updated

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

New Hyde Park : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

New Hyde Park :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

New York : Columbia University Medical Center Updated

Efficacy Study of AeroVanc for the Treatment of Persistent MRSA Lung Infection in Cystic Fibrosis Patients

New York : Site Reference ID/Investigator# 76773

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

New York : Cunnar Esiason Adult CF and Lung Program Updated

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

New York :

Rollover Study of Ivacaftor in Subjects With Cystic Fibrosis and a Non G551D CFTR Mutation

New York :

Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation

Rochester : Updated

A Study of Lumacaftor in Combination With Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older Who Are Homozygous for the F508del-CFTR Mutation (TRANSPORT)

Rochester : University of Rochester Medical Center

I Change Adherence & Raise Expectations

Rochester : Site Reference ID/Investigator# 92713

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Syracuse : Site Reference ID/Investigator# 78912

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Syracuse : SUNY Upstate University Updated

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Syracuse :

Rollover Study of Ivacaftor in Subjects With Cystic Fibrosis and a Non G551D CFTR Mutation

Syracuse :

Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation

Valhalla :

Rollover Study of Ivacaftor in Subjects With Cystic Fibrosis and a Non G551D CFTR Mutation

Valhalla :

Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation

Chapel Hill : Investigational Site

A Phase 1 Study to Characterize the Effect of GS-5737 Enhancement of Mucociliary Clearance (MCC) in Healthy Subjects

Chapel Hill : University of North Carolina Updated

Efficacy Study of AeroVanc for the Treatment of Persistent MRSA Lung Infection in Cystic Fibrosis Patients

Chapel Hill : Site Reference ID/Investigator# 78937

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Chapel Hill :

Rollover Study of Ivacaftor in Subjects With Cystic Fibrosis and a Non G551D CFTR Mutation

Chapel Hill : University of North Carolina

Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation

View More »

Chapel Hill : UNC at Chapel Hill

Safety and Tolerability Trial of Inhaled Alpha1-Proteinase Inhibitor (Human), Hydrophobic Chromatography Process (Alpha-1 HC) in Subjects With Cystic Fibrosis

Chapel Hill :

Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation

Chapel Hill : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Durham : Duke University Medical Center

I Change Adherence & Raise Expectations

Durham : Duke University Medical Center Updated

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Bismarck : St. Alexius Medical Center

A research study for patients with Cystic Fibrosis

Bismarck : St. Alexius Medical Center

A study for cystic fibrosis patients who might have a condition called Fibrosing Colonopathy (FC).

View More »

Bismarck : Site Reference ID/Investigator# 78958

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Akron : Akron Children's Hospital

I Change Adherence & Raise Expectations

Akron : Site Reference ID/Investigator# 79263

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Akron : Akron Children's Hospital Updated

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Cincinnati : Site Reference ID/Investigator# 79375

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Cincinnati : UC Health - University of Cincinnati Updated

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

View More »

Cincinnati : Cincinnati Children's Hospital Updated

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Cincinnati : Cincinnati Children's Hospital

Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation

Cincinnati : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Cincinnati :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Cleveland : Rainbow Babies and Children's Hospital / University Hospitals Case Medical Center Updated

Efficacy Study of AeroVanc for the Treatment of Persistent MRSA Lung Infection in Cystic Fibrosis Patients

Cleveland : Rainbow Babies and Children's Hospital

I Change Adherence & Raise Expectations

Cleveland : Rainbow Babies and Children's Hospital

Safety and Tolerability Trial of Inhaled Alpha1-Proteinase Inhibitor (Human), Hydrophobic Chromatography Process (Alpha-1 HC) in Subjects With Cystic Fibrosis

Cleveland :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Columbus : Nationwide Children's Hospital Updated

Efficacy Study of AeroVanc for the Treatment of Persistent MRSA Lung Infection in Cystic Fibrosis Patients

Columbus : Nationwide Children's Hospital

I Change Adherence & Raise Expectations

Columbus : Site Reference ID/Investigator# 78897

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Columbus : Nationwide Children's Hospital

Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation

Columbus : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Columbus :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Columbus : Nationwide Children's Hospital

Use of Levemir® Improves Metabolic and Clinical Status in Cystic Fibrosis-related Diabetes (CFRD)

Dayton : The Children's Medical Center of Dayton Updated

Efficacy Study of AeroVanc for the Treatment of Persistent MRSA Lung Infection in Cystic Fibrosis Patients

Dayton : Site Reference ID/Investigator# 78915

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Dayton :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Toledo : Toledo Children's Hospital

I Change Adherence & Raise Expectations

Toledo : Site Reference ID/Investigator# 78913

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Toledo : The Toledo Hospital/Toledo Children's Hospital CF Center Updated

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Toledo :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Oklahoma City : Updated

A Study of Lumacaftor in Combination With Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older Who Are Homozygous for the F508del-CFTR Mutation (TRANSPORT)

Oklahoma City : Santiago Reyes, MD Updated

Efficacy Study of AeroVanc for the Treatment of Persistent MRSA Lung Infection in Cystic Fibrosis Patients

Oklahoma City : Santiago Reyes, MD Updated

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Oklahoma City : OU Health Sciences Center Updated

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Oklahoma City : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

View More »

Oklahoma City :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Hershey : Penn State Milton S. Hershey Medical Center Updated

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Hershey : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Hershey :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Philadelphia : Site Reference ID/Investigator# 76777

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Philadelphia : University of Pennsylvania Updated

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

View More »

Philadelphia : Drexel University College of Medicine Updated

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Philadelphia :

Rollover Study of Ivacaftor in Subjects With Cystic Fibrosis and a Non G551D CFTR Mutation

Philadelphia :

Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation

Philadelphia :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Pittsburgh : Children's Hospital of Pittsburgh of UPMC Updated

Efficacy Study of AeroVanc for the Treatment of Persistent MRSA Lung Infection in Cystic Fibrosis Patients

Pittsburgh : Children's Hospital of Pittsburgh Updated

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Pittsburgh :

Rollover Study of Ivacaftor in Subjects With Cystic Fibrosis and a Non G551D CFTR Mutation

Pittsburgh :

Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation

Pittsburgh : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Pittsburgh :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Charleston : Medical University of South Carolina Updated

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Charleston :

Rollover Study of Ivacaftor in Subjects With Cystic Fibrosis and a Non G551D CFTR Mutation

Charleston : Medical University of South Carolina

Safety and Tolerability Trial of Inhaled Alpha1-Proteinase Inhibitor (Human), Hydrophobic Chromatography Process (Alpha-1 HC) in Subjects With Cystic Fibrosis

Charleston :

Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation

Charleston : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

View More »

Charleston :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Columbia : University Specialty Clinic - Pediatric Pulmonology Updated

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Washington :

A Study of the Comparable Efficacy and Safety of Pulmozyme (Dornase Alfa) Delivered by the eFlow Rapid Nebulizer System in Patients With Cystic Fibrosis

Sioux Falls : Updated

A Study of Lumacaftor in Combination With Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older Who Are Homozygous for the F508del-CFTR Mutation (TRANSPORT)

Sioux Falls :

A Study of the Comparable Efficacy and Safety of Pulmozyme (Dornase Alfa) Delivered by the eFlow Rapid Nebulizer System in Patients With Cystic Fibrosis

Sioux Falls : Site Reference ID/Investigator# 78909

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Knoxville : University of Tennessee Medical Center Updated

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Knoxville :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Memphis : Children's Foundation Research Institute/UTHSC Updated

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Memphis :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Nashville :

A Study of the Comparable Efficacy and Safety of Pulmozyme (Dornase Alfa) Delivered by the eFlow Rapid Nebulizer System in Patients With Cystic Fibrosis

View More »

Nashville : Vanderbilt Children's Hospital Updated

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Nashville :

Rollover Study of Ivacaftor in Subjects With Cystic Fibrosis and a Non G551D CFTR Mutation

Nashville :

Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation

Nashville :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Austin : Site Reference ID/Investigator# 79213

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Austin :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Dallas : UT Southwestern Medical Center Updated

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Dallas :

Rollover Study of Ivacaftor in Subjects With Cystic Fibrosis and a Non G551D CFTR Mutation

Dallas :

Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation

View More »

Dallas :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Fort Worth : Site Reference ID/Investigator# 78949

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Fort Worth : Cook Children's Medical Center Updated

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Fort Worth :

Rollover Study of Ivacaftor in Subjects With Cystic Fibrosis and a Non G551D CFTR Mutation

Fort Worth :

Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation

Houston : Baylor College of Medicine and Texas Children's Hospital Updated

Efficacy Study of AeroVanc for the Treatment of Persistent MRSA Lung Infection in Cystic Fibrosis Patients

Houston :

Rollover Study of Ivacaftor in Subjects With Cystic Fibrosis and a Non G551D CFTR Mutation

Houston :

Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation

San Antonio :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Tyler : Site Reference ID/Investigator# 79261

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Salt Lake City : University of Utah

A Study of Sweat Testing Using a Quantitative Patch

Salt Lake City : Primary Children's Medical Center

I Change Adherence & Raise Expectations

Salt Lake City : University of Utah Updated

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Salt Lake City :

Rollover Study of Ivacaftor in Subjects With Cystic Fibrosis and a Non G551D CFTR Mutation

Salt Lake City :

Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CTFR Gating Mutation

View More »

Salt Lake City :

Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation

Salt Lake City : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Colchester : Vermont Lung Center at the University of Vermont Updated

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Colchester : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Colchester :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Charlottesville : Site Reference ID/Investigator# 78942

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Charlottesville : University of Virginia Updated

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Norfolk : Site Reference ID/Investigator# 79293

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Norfolk : Children's Hospital of the King's Daughters Updated

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Richmond : Site Reference ID/Investigator# 78955

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

View More »

Richmond :

Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation

Richmond :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Seattle : Seattle Children's Hospital

I Change Adherence & Raise Expectations

Seattle :

Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation

Seattle : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Spokane : Site Reference ID/Investigator# 79257

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Morgantown : West Virginia University

I Change Adherence & Raise Expectations

Morgantown : Site Reference ID/Investigator# 78953

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Morgantown : West Virginia University Updated

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Morgantown :

Rollover Study of Ivacaftor in Subjects With Cystic Fibrosis and a Non G551D CFTR Mutation

Morgantown :

Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation

Madison : American Family Children's Hospital

A Study of Sweat Testing Using a Quantitative Patch

Madison : Site Reference ID/Investigator# 78944

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Madison :

Rollover Study of Ivacaftor in Subjects With Cystic Fibrosis and a Non G551D CFTR Mutation

Madison :

Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation

Madison :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

View More »

Milwaukee : Site Reference ID/Investigator# 79294

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Milwaukee : Childrens Hospital of Wisconsin Updated

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

Milwaukee :

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Clayton : Novartis Investigative Site

Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis

New Lambton Heights : Novartis Investigative Site

Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis

Parkville : Novartis Investigative Site

Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis

Antwerp : University Hospital Antwerp - Universitair Ziekenhuis Antwerpen (UZA)

Safety and Efficacy Study of 2 Pancreatic Enzymes for Treatment of Exocrine Pancreatic Insufficiency in Cystic Fibrosis.

Leuven :

Rollover Study of Ivacaftor in Subjects With Cystic Fibrosis and a Non G551D CFTR Mutation

Pleven : Clinic of Paediatric Diseases at UMHAT Dr Georgi Stranski

Safety and Efficacy Study of 2 Pancreatic Enzymes for Treatment of Exocrine Pancreatic Insufficiency in Cystic Fibrosis.

Plovdiv : Clinic of Genetic and Paediatric Diseases at UMHAT Sveti Georgi

Safety and Efficacy Study of 2 Pancreatic Enzymes for Treatment of Exocrine Pancreatic Insufficiency in Cystic Fibrosis.

Ruse : Specialized Hospital for Active Treatment of Pulmological and Phtisiatric Disease

Safety and Efficacy Study of 2 Pancreatic Enzymes for Treatment of Exocrine Pancreatic Insufficiency in Cystic Fibrosis.

Varna : Multiprofile Clinic for Specialized Pediatric Clinic at MHAT Sveta Marina

Safety and Efficacy Study of 2 Pancreatic Enzymes for Treatment of Exocrine Pancreatic Insufficiency in Cystic Fibrosis.

Calgary : Novartis Investigative Site

Randomized, Controlled Study of CF Patients Between 3 Months and Less Than 7 Years

Halifax : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Montreal : Novartis Investigative Site

Randomized, Controlled Study of CF Patients Between 3 Months and Less Than 7 Years

Toronto : Novartis Investigative Site

Randomized, Controlled Study of CF Patients Between 3 Months and Less Than 7 Years

Toronto : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

View More »

Vancouver : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Winnipeg : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Bron : Centre de ressources et de compétences pour la mucovisidose, enfants

Pharmacokinetic Bioequivalence Study of Nebcinal® 150mg/3ml Administered by Aeroneb® Idehaler® Versus Tobi® 300mg/5ml Administered by Pari LC Plus®

Lyon : Centre de Ressource et de Compétence Mucoviscidose Pédiatrique Centre de Référence Mucoviscidose

Pharmacokinetic Bioequivalence Study of Nebcinal® 150mg/3ml Administered by Aeroneb® Idehaler® Versus Tobi® 300mg/5ml Administered by Pari LC Plus® /Pulmoaid® in Patients With Cystic Fibrosis

Berlin : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Bochum : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Dresden : Novartis Investigative Site

Randomized, Controlled Study of CF Patients Between 3 Months and Less Than 7 Years

Erlangen : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Essen : Novartis Investigative Site

Randomized, Controlled Study of CF Patients Between 3 Months and Less Than 7 Years

View More »

Frankfurt : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Frankfurt : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Hannover : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Jena : Jena University Hospital, Universitaetsklinikum Jena

Control of Steatorrhea in Patients With Cystic Fibrosis and Pancreatic Insufficiency

Jena : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Koeln : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Koln : Novartis Investigative Site

Randomized, Controlled Study of CF Patients Between 3 Months and Less Than 7 Years

München : Klinikum der Universitat Munchen Medizinische Klinik-Innenstadt

Control of Steatorrhea in Patients With Cystic Fibrosis and Pancreatic Insufficiency

Munich : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Tubingen : University Children's Clinic Tubingen

Control of Steatorrhea in Patients With Cystic Fibrosis and Pancreatic Insufficiency

Patras : Novartis Investigative site

Randomized, Controlled Study of CF Patients Between 3 Months and Less Than 7 Years

Thessaloniki : Novartis Investigative Site

Randomized, Controlled Study of CF Patients Between 3 Months and Less Than 7 Years

Debrecen : Novartis Investigative Site

Randomized, Controlled Study of CF Patients Between 3 Months and Less Than 7 Years

Kaposvar : Novartis Investigative Site

Randomized, Controlled Study of CF Patients Between 3 Months and Less Than 7 Years

Szeged : Novartis Investigative Site

Randomized, Controlled Study of CF Patients Between 3 Months and Less Than 7 Years

Kagawa : Site Reference ID/Investigator# 65530 Updated

Special Investigation (All Cases) of LipaCreon in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis

Kagoshima : Site Reference ID/Investigator# 65527 Updated

Special Investigation (All Cases) of LipaCreon in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis

Kanazawa : Site Reference ID/Investigator# 65529 Updated

Special Investigation (All Cases) of LipaCreon in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis

Nagoya : Site Reference ID/Investigator# 73813 Updated

Special Investigation (All Cases) of LipaCreon in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis

Nagoya : Site reference ID/Investigator # 96698 Updated

Special Investigation (All Cases) of LipaCreon in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis

View More »

Obu : Site reference ID/Investigator # 93736 Updated

Special Investigation (All Cases) of LipaCreon in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis

Sendai : Site Reference ID/Investigator# 65528 Updated

Special Investigation (All Cases) of LipaCreon in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis

Tokyo : Site Reference ID/Investigator# 67122 Updated

Special Investigation (All Cases) of LipaCreon in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis

Tsukuba : Site reference ID/Investigator # 93735 Updated

Special Investigation (All Cases) of LipaCreon in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis

Tsukuba : Site Reference ID/Investigator# 88673 Updated

Special Investigation (All Cases) of LipaCreon in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis

Gdansk : Specjalistyczny Zespół Opieki Zdrowotnej nad Matką i Dzieckiem Poradnia Leczenia Mukowiscydozy

Control of Steatorrhea in Patients With Cystic Fibrosis and Pancreatic Insufficiency

Gdansk : Specjalistyczny Zespot Opieki Zdrowotnej nad Matka i Dzieckiem Poradnia Leczenia Mukowiscydozy

Safety and Efficacy Study of 2 Pancreatic Enzymes for Treatment of Exocrine Pancreatic Insufficiency in Cystic Fibrosis.

Karpacz : Centrum Pulmonologii i Alergologii w Karpaczu

Safety and Efficacy Study of 2 Pancreatic Enzymes for Treatment of Exocrine Pancreatic Insufficiency in Cystic Fibrosis.

Lodzi : Wojewodzki Szpital Specjalistyczny im Kopernika

Safety and Efficacy Study of 2 Pancreatic Enzymes for Treatment of Exocrine Pancreatic Insufficiency in Cystic Fibrosis.

Lublin : Dziecięcy Szpital Kliniczny im. Prof. Antoniego Gębali

Control of Steatorrhea in Patients With Cystic Fibrosis and Pancreatic Insufficiency

View More »

Lublin : ALERGOTEST s.c Specjalistyczne Centrum Medyczne

Safety and Efficacy Study of 2 Pancreatic Enzymes for Treatment of Exocrine Pancreatic Insufficiency in Cystic Fibrosis.

Poznan : Szpital Kliniczny im Karola Jonschera

Control of Steatorrhea in Patients With Cystic Fibrosis and Pancreatic Insufficiency

Poznan : Szpital Kliniczny im Karola Jonschera

Safety and Efficacy Study of 2 Pancreatic Enzymes for Treatment of Exocrine Pancreatic Insufficiency in Cystic Fibrosis.

Rabka Zdrój : NZOZ Sanatorium Cassia Villa Medica

Control of Steatorrhea in Patients With Cystic Fibrosis and Pancreatic Insufficiency

Rabka Zdrój : NZOZ Sanatorium Cassia Villa Medica

Safety and Efficacy Study of 2 Pancreatic Enzymes for Treatment of Exocrine Pancreatic Insufficiency in Cystic Fibrosis.

Rzeszow : NZOZ Podkarpacki Osrodek Pulmonologii i Alergologii

Control of Steatorrhea in Patients With Cystic Fibrosis and Pancreatic Insufficiency

Rzeszow : NZOZ Podkarpacki Osrodek Pulmonologii i Alergologii

Safety and Efficacy Study of 2 Pancreatic Enzymes for Treatment of Exocrine Pancreatic Insufficiency in Cystic Fibrosis.

Warszawa : IRMED Irena Wojciechowska

Safety and Efficacy Study of 2 Pancreatic Enzymes for Treatment of Exocrine Pancreatic Insufficiency in Cystic Fibrosis.

Warszawa : Centrum Zdrowia Matki, Dziecka i Mlodziezy

Safety and Efficacy Study of 2 Pancreatic Enzymes for Treatment of Exocrine Pancreatic Insufficiency in Cystic Fibrosis.

Doha : Hamad Medical Corporation

Blood Collection From Individuals With Lung Disease for Genetic Studies (Qatar)

Kazan : Novartis Investigative Site

Randomized, Controlled Study of CF Patients Between 3 Months and Less Than 7 Years

Moscow : Novartis Investigative Site

Randomized, Controlled Study of CF Patients Between 3 Months and Less Than 7 Years

Voronezh : Novartis Investigative Site

Randomized, Controlled Study of CF Patients Between 3 Months and Less Than 7 Years

Yaroslavl : Novartis Investigative Site

Randomized, Controlled Study of CF Patients Between 3 Months and Less Than 7 Years

Sabadell : Novartis Investigative Site

Assess the Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis

Lausanne : Novartis Investigative Site

Randomized, Controlled Study of CF Patients Between 3 Months and Less Than 7 Years

Zurich : Novartis Investigative Site

Randomized, Controlled Study of CF Patients Between 3 Months and Less Than 7 Years

Belfast : Celerion

A Safety and Tolerability Study OF PUR118 In Subjects With Cystic Fibrosis

Belfast :

Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation

Cambridge : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Cardiff : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Edinburgh :

Rollover Study of Ivacaftor in Subjects With Cystic Fibrosis and a Non G551D CFTR Mutation

View More »

Edinburgh :

Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation

Liverpool : Liverpool Heart & Chest Hospital

A Cross-over Study of OligoG in Subjects With Cystic Fibrosis. Fibrosis

Liverpool : Liverpool Heart and Chest Hospital

Safety and Efficacy Study of 2 Pancreatic Enzymes for Treatment of Exocrine Pancreatic Insufficiency in Cystic Fibrosis.

London : Royal Brompton Hospital, Department of Respiratory Medicine

Extension Study of Arikace™ in CF Patients With Chronic Pseudomonas Aeruginosa Infection

London : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Manchester : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation

Sheffield : Sheffield Children's Hospital, The Academic Unit of Child Health

Safety and Efficacy Study of 2 Pancreatic Enzymes for Treatment of Exocrine Pancreatic Insufficiency in Cystic Fibrosis.

Southhampton : Vertex Investigational Site

Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation